[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1888 

# __Inadequate vaccine efficacy__

## Category to which it belongs

* [Limited capacity, high demand, waning effectiveness, distribution difficulties, and access disparities hinder efficient vaccination efforts.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_25.md)

## Closest similar item

* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_430.md)
* [Inadequate vaccination coverage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3186.md)
* [Waning efficacy of vaccines](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_861.md)
* [Lack of vaccine or cure](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1733.md)
* [Vaccine availability, vaccine hesitancy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3118.md)
* [Uncertainty of vaccine effectiveness, time-consuming research process](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3031.md)
* [Vaccine hesitancy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1886.md)
* [Hesitation to vaccinate](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2056.md)
* [Lack of covid-19 vaccine](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2277.md)
* [Difficulty in vaccine distribution](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_519.md)

## Description of the risk

Waning efficacy of vaccines against re-infections.

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Scale_1.md)

## Type of impact of the risk (according to ISO37100)

* [Safety and security](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Purpose_5.md)

## Type of purpose of the risk (according to ISO37100)

* [Safety and security](https://github.com/mm80843/T3.5/blob/pages/ISO/PBN__ISO_Impact_0.md)

## Mitigations of this risk

* [Improve vaccine efficacy through research and development.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2509.md)

## Name of the risk

Decreased overall protection against COVID-19 re-infections.

## Stakeholders who can mitigate this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Vaccine manufacturers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1290.md)

## Articles mentionning the risk

* [Contributions to the mitigation of the COVID-19 pandemic](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_245.md)

## People affected by this risk

* [Vaccinated individuals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1289.md)

## Technologies linked to the risk

* [Vaccine development and improvement technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1305.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_5.md)

